Cargando…
A nurse practitioner model of care in the era of direct acting antiviral therapy for hepatitis C virus infection
BACKGROUND AND AIM: Direct‐acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection has resulted in high rates of successful disease cure; however, not enough healthcare providers are available to deliver treatment to the population living with chronic HCV. To demonstrate that a nurse pr...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171160/ https://www.ncbi.nlm.nih.gov/pubmed/34124384 http://dx.doi.org/10.1002/jgh3.12552 |
_version_ | 1783702379663720448 |
---|---|
author | Nario, Steffanie Reynauld, Benhur Blacklaws, Helen Boden, Sharon Sud, Rishi Hawken, Glenn Singh, Satbir Herba, Karl Panetta, James Pang, James |
author_facet | Nario, Steffanie Reynauld, Benhur Blacklaws, Helen Boden, Sharon Sud, Rishi Hawken, Glenn Singh, Satbir Herba, Karl Panetta, James Pang, James |
author_sort | Nario, Steffanie |
collection | PubMed |
description | BACKGROUND AND AIM: Direct‐acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection has resulted in high rates of successful disease cure; however, not enough healthcare providers are available to deliver treatment to the population living with chronic HCV. To demonstrate that a nurse practitioner (NP) model of care is non‐inferior to specialist gastroenterologist (SG) management of HCV infection, as measured by sustained viral response at 12 weeks (SVR(12)) after initiation of DAA therapy. DESIGN: Retrospective cohort database study. SETTING: Single‐center outpatient study, Central Coast Local Health District (CCLHD). PARTICIPANTS: All patients with chronic HCV treated in the CCLHD Liver Clinic in the period 3rd March 2016 to 31st May 2019 were retrospectively analyzed. In this time period, a total of 1638 patients with chronic HCV had completed treatment. Seven hundred and thirty‐four patients were excluded (733 pre‐PBS listing for DAAs and 1 not treated with DAA). Nine hundred and four patients were eligible for the study, of which 541 were managed by an SG, and 363 managed by an NP. MAIN OUTCOME MEASURES: Data were collected on patient demographics, genotype, fibrosis score, and presence of cirrhosis. Primary end point was number of patients achieving SVR(12). RESULTS: Of the 904 patients treated with DAA, 764 (84.5%) achieved SVR(12). There was no statistical difference (P > 0.05) in achieving SVR(12) between patients treated by an SP (n = 481, 88.9%) and those treated by an NP (n = 281, 77.4%). CONCLUSION: An NP model of care is non‐inferior to SG management of HCV infection, as evidenced by equivocal success in achieving SVR(12) between the two treatment groups. Therefore, an NP model of care is a viable option in the era of DAA therapy for HCV infection. Ongoing investment into the delivery of NP care could increase treatment uptake of HCV, with the aim of decreasing overall burden of disease. |
format | Online Article Text |
id | pubmed-8171160 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wiley Publishing Asia Pty Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-81711602021-06-11 A nurse practitioner model of care in the era of direct acting antiviral therapy for hepatitis C virus infection Nario, Steffanie Reynauld, Benhur Blacklaws, Helen Boden, Sharon Sud, Rishi Hawken, Glenn Singh, Satbir Herba, Karl Panetta, James Pang, James JGH Open Original Articles BACKGROUND AND AIM: Direct‐acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection has resulted in high rates of successful disease cure; however, not enough healthcare providers are available to deliver treatment to the population living with chronic HCV. To demonstrate that a nurse practitioner (NP) model of care is non‐inferior to specialist gastroenterologist (SG) management of HCV infection, as measured by sustained viral response at 12 weeks (SVR(12)) after initiation of DAA therapy. DESIGN: Retrospective cohort database study. SETTING: Single‐center outpatient study, Central Coast Local Health District (CCLHD). PARTICIPANTS: All patients with chronic HCV treated in the CCLHD Liver Clinic in the period 3rd March 2016 to 31st May 2019 were retrospectively analyzed. In this time period, a total of 1638 patients with chronic HCV had completed treatment. Seven hundred and thirty‐four patients were excluded (733 pre‐PBS listing for DAAs and 1 not treated with DAA). Nine hundred and four patients were eligible for the study, of which 541 were managed by an SG, and 363 managed by an NP. MAIN OUTCOME MEASURES: Data were collected on patient demographics, genotype, fibrosis score, and presence of cirrhosis. Primary end point was number of patients achieving SVR(12). RESULTS: Of the 904 patients treated with DAA, 764 (84.5%) achieved SVR(12). There was no statistical difference (P > 0.05) in achieving SVR(12) between patients treated by an SP (n = 481, 88.9%) and those treated by an NP (n = 281, 77.4%). CONCLUSION: An NP model of care is non‐inferior to SG management of HCV infection, as evidenced by equivocal success in achieving SVR(12) between the two treatment groups. Therefore, an NP model of care is a viable option in the era of DAA therapy for HCV infection. Ongoing investment into the delivery of NP care could increase treatment uptake of HCV, with the aim of decreasing overall burden of disease. Wiley Publishing Asia Pty Ltd 2021-05-20 /pmc/articles/PMC8171160/ /pubmed/34124384 http://dx.doi.org/10.1002/jgh3.12552 Text en © 2021 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Nario, Steffanie Reynauld, Benhur Blacklaws, Helen Boden, Sharon Sud, Rishi Hawken, Glenn Singh, Satbir Herba, Karl Panetta, James Pang, James A nurse practitioner model of care in the era of direct acting antiviral therapy for hepatitis C virus infection |
title | A nurse practitioner model of care in the era of direct acting antiviral therapy for hepatitis C virus infection |
title_full | A nurse practitioner model of care in the era of direct acting antiviral therapy for hepatitis C virus infection |
title_fullStr | A nurse practitioner model of care in the era of direct acting antiviral therapy for hepatitis C virus infection |
title_full_unstemmed | A nurse practitioner model of care in the era of direct acting antiviral therapy for hepatitis C virus infection |
title_short | A nurse practitioner model of care in the era of direct acting antiviral therapy for hepatitis C virus infection |
title_sort | nurse practitioner model of care in the era of direct acting antiviral therapy for hepatitis c virus infection |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171160/ https://www.ncbi.nlm.nih.gov/pubmed/34124384 http://dx.doi.org/10.1002/jgh3.12552 |
work_keys_str_mv | AT nariosteffanie anursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT reynauldbenhur anursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT blacklawshelen anursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT bodensharon anursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT sudrishi anursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT hawkenglenn anursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT singhsatbir anursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT herbakarl anursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT panettajames anursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT pangjames anursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT nariosteffanie nursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT reynauldbenhur nursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT blacklawshelen nursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT bodensharon nursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT sudrishi nursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT hawkenglenn nursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT singhsatbir nursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT herbakarl nursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT panettajames nursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection AT pangjames nursepractitionermodelofcareintheeraofdirectactingantiviraltherapyforhepatitiscvirusinfection |